The Patent Finder

Foundation Medicine, Inc.

43 patents currently held · Updated Nov 18, 2026
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 13, 2026
    The maintenance fee for Therapeutic and Diagnostic Methods for Cancer (US 11,674,962) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
  • 1 fee due Feb 15, 2027
    The maintenance fee for Methods of Treating Cancer (US 11,725,247) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
  • 1 fee due Apr 3, 2027
    The maintenance fee for Methods of treating cholangiocarcinoma (US 11,771,698) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.
  • 1 fee due Sep 29, 2027
    The maintenance fee for Novel KIF5B-RET Fusion Molecules and Uses Thereof (US 9,297,011) comes due Sep 29, 2027. Unpaid by Mar 29, 2028, it lapses early.
  • 1 fee due Oct 16, 2027
    The maintenance fee for Multigene Analysis of Tumor Samples (US 11,959,141) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
  • 1 fee due Nov 17, 2027
    The maintenance fee for Optimization of Multigene Analysis of Tumor Samples (US 9,340,830) comes due Nov 17, 2027. Unpaid by May 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 11,118,213Optimization of Multigene Analysis of Tumor Samples
In force
 · Low confidence
In forceLow confidence
US 11,136,619Optimization of Multigene Analysis of Tumor Samples
In force
 · Low confidence
In forceLow confidence
US 11,421,265Optimization of Multigene Analysis of Tumor Samples
In force
 · Low confidence
In forceLow confidence
US 12,180,540Optimization of Multigene Analysis of Tumor Samples
In force
 · Low confidence
In forceLow confidence
US 9,297,011Novel KIF5B-RET Fusion Molecules and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 9,884,060Novel KIF5B-RET Fusion Molecules and Uses Thereof
In force
 · Low confidence
In forceLow confidence
US 9,340,830Optimization of Multigene Analysis of Tumor Samples
In force
 · High confidence
In forceHigh confidence
US 10,093,983Novel Estrogen Receptor Mutations and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 11,286,532Novel Estrogen Receptor Mutations and Uses Thereof
In force
 · Low confidence
In forceLow confidence
US 12,116,638Novel Estrogen Receptor Mutations and Uses Thereof
In force
 · Low confidence
In forceLow confidence
10 of 43 patents shown.
Pro members see all 43.
Pro members: see all 43 patents
Also on record, not counted in the 43: 6 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

62 pending · 13 abandoned · 24 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited